Administration Agreements in the Pharmaceuticals Industry
8 Contracts & Agreements
- Bright Green Corp (2 contracts)
- MARINUS PHARMACEUTICALS INC (1)
- NOVEN PHARMACEUTICALS INC (4)
- QUESTCOR PHARMACEUTICALS INC (1)
- Letter Agreement re: Amendment to Tranche C Commitment, dated May 23, 2022, by and among Marinus Pharmaceuticals, Inc., as Borrower, Oaktree Fund Administration, LLC, as... (MARINUS PHARMACEUTICALS INC, Filed With SEC on May 25, 2022)
- Memorandum of Agreement between Bright Green Corporation and the Department of Justice, Drug Enforcement 7 Administration (Bright Green Corp, Filed With SEC on May 9, 2022)
- Memorandum of Agreement between Bright Green Corporation and the Department of Justice, Drug Enforcement 7 Administration (Bright Green Corp, Filed With SEC on May 5, 2022)
- Daytrana, the first and only transdermal patch approved by the United States Food & Drug Administration (FDA) for the treatment of ADHD (NOVEN PHARMACEUTICALS INC, Filed With SEC on March 13, 2009)
- Daytrana, the first and only transdermal patch approved by the United States Food & Drug Administration (FDA) for the treatment of ADHD (NOVEN PHARMACEUTICALS INC, Filed With SEC on March 13, 2009)
- Daytrana, the first and only transdermal patch approved by the United States Food & Drug Administration (FDA) for the treatment of ADHD (NOVEN PHARMACEUTICALS INC, Filed With SEC on March 13, 2009)
- Daytrana, the first and only transdermal patch approved by the United States Food & Drug Administration (FDA) for the treatment of ADHD (NOVEN PHARMACEUTICALS INC, Filed With SEC on March 13, 2009)
- /s/ Fredric I. Storch Date: October 13, 2006 Fredric I. Storch Senior Director, Human Resources and Administration Accepted by: /s/ Eric Liebler Date: October 16, 2006 Eric Liebler (QUESTCOR PHARMACEUTICALS INC, Filed With SEC on October 18, 2006)
